Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immuron Limited ( (AU:IMC) ) has shared an update.
Immuron Limited has issued 473,880 ordinary shares without disclosure under Part 6D.2 of the Corporations Act, as per the notice under section 708A(5)(e). The company confirms compliance with relevant provisions of the Corporations Act and states there is no ‘excluded information’ that needs to be disclosed, indicating transparency in its operations.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases.
Average Trading Volume: 78,213
Technical Sentiment Signal: Sell
Current Market Cap: A$14.97M
For an in-depth examination of IMC stock, go to TipRanks’ Overview page.